Author:
Masud Alam Md,Huang Yue,Oppenheim Joost J.,Yang De
Subject
Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy
Reference39 articles.
1. Lipopeptides for vaccine development;Hamley;Bioconjug. Chem.,2021
2. Development of an enzyme-mediated, site-specific method to conjugate toll-like receptor 2 agonists onto protein antigens: toward a broadly protective, four component, group a streptococcal self-adjuvanting lipoprotein-fusion combination vaccine, ACS;Xu;Infect. Dis.,2020
3. Design, synthesis, and preliminary immunological studies of MUC1-based antitumor vaccines adjuvanted with R- and S-FSL-1;Liu;ACS Med. Chem. Lett.,2020
4. Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine
5. Toll-like receptor 2 and 6 agonist fibroblast-stimulating lipopeptide increases expression and secretion of CXCL1 and CXCL2 by uveal melanocytes;Hu;Exp. Eye Res.,2022